Saudia Cargo has added Tower Cold Chain to its approved roster of temperature-controlled containers for shipping pharmaceutical, biotech and life science products, in a new global rental agreement.

The deal reinforces Saudia Cargo’s commitment to having the broadest possible selection of cold chain products (both in terms of cargo size and temperature requirements) to serve the growing requirements of pharmaceutical customers from around the world.

“Given these conditions, we have an extra duty of care to customers to ensure due diligence in choosing our pharmaceutical cold chain partners,” commented Adel Elshazly Global Product Manager at Saudia Cargo. “Tower’s passive solutions are proven to maintain temperatures up to 120 hours, without any need for intervention or external power.

“The breadth of the Tower range means we can extend our network and provide customers with greater choice, including the ability to ship pharmaceuticals on narrow-bodied as well as wide-bodied aircrafts” Adel Elshazly stated.

“Tower has a growing network of hubs, including locations where much of our business hails from airports such as Frankfurt, Zurich and Milan.  The proximity and availability of Tower containers at these hubs means we can offer seamless and direct delivery to our airports”.

“We choose our partners carefully and we know Tower is a pillar of the pharmaceutical container market, we are delighted to announce this partnership which will take us to new heights for global customer satisfaction” added Adel Elshazly.

Tower’s Chief Executive Niall Balfour said: “As a global company, this partnership is a vital part of our commitment to customers. Saudia Cargo gives us a valuable gateway into the Middle East, and in turn we are honoured to be able to help them meet customer demand for robust, reliable, and reusable pharmaceutical cold chain solutions.”